SCROLL NEWS / DISCOVERY
Search headlines
Find the stories shaping the conversation.
Results for " First " 19,257 found 🔀 AI-powered Shuffle
Hollywood gets into the microdrama race as mobile-first storytelling draws stars and major studios
Mobile-first serialized storytelling is rapidly becoming one of entertainment's fastest-growing businesses.
Hollywood gets into the microdrama race as mobile-first storytelling draws stars and major studios
While much of Hollywood was consumed by the streaming wars, Issa Rae was studying a different mode of entertainment thousands of miles away: microdramas. No stranger to creating a successful online s...
UFC Baku early weigh ins results
Ultimate Fighting Championship (UFC) will stage its early and official weigh ins at 9 a.m. local time for this weekend’s UFC Baku mixed martial arts (MMA) event on Paramount+. Unfortunately for stateside fight fans, Baku is eight hours ahead of Eastern Standard Time, so most of us will be asleep by the time the first […]
Salpointe flag football QB named MaxPreps Freshman of the Year
It is the first year that MaxPreps is putting together an All-American team as the sport continues to gain popularity.
👀 Brazil learn first World Cup knockout opponents
The Brazil National Team already knows who it will face in the FIFA World Cup Round of 32.Vini Jr., Matheus Cunha & Co. will take on Japan in their first knockout match of the World Cup. Japan finish...
Health officials: State's first West Nile virus-positive mosquito of the year found in Berkshires
“With warmer weather and summer officially beginning this week, it is the time of year when we typically begin detecting West Nile virus in mosquito populations,” a public health official said.
Lionel Richie postpones concert at United Center in Chicago following health scare at Minnesota show
Lionel Richie has postponed his concert this week at the United Center in Chicago following his health scare at during his first performance in a tour with Earth, Wind and Fire.
M6 MacBook Pro Expected This Year With Apple's First 2nm Chip
Apple could launch an updated base model 14-inch MacBook Pro with an M6 chip as soon as this year, reports Bloomberg. There could also be M6 chip updates for the Mac mini, iMac, and MacBook Air, but Apple is testing an M6 MacBook Pro. Apple plans to introduce the M6 in late 2026, and for the first time, it will be a standalone chip. Apple is not working on M6 Pro or M6 Max chips, and will hold off on higher-end chip options until the M7 series launches in 2027.
Golden State Valkyries employee named in Sports Business Journal's Forty under 40 list
The Golden State Valkyries have created a winning culture on and off the court. After making WNBA history last season becoming the first expansion team to reach the playoffs, the success is also extending throughout the organization.
Making Our Own Luck
We are cross-posting a piece that former NIH official Kris Willis wrote for Macroscience. Kris is now the President and Founder of the Woodley Park Institute, for which I’m a board member. Picking winners or hedging bets? Federal science agencies have long wrestled with the question of how to ensure their billions of dollars of grants and contracts result in maximum benefits for Americans. On the surface, it might seem that a goal-oriented, interventionist style of management would be the best policy: prioritize our most pressing problems and distribute funding accordingly.This top-down strategy creates a unique hazard, though: bad choices can send resources in the wrong direction, resulting in slow progress that impedes the delivery of tangible benefits to citizens. Moreover, if decision makers pursue an applied advance when the underlying scientific principles remain poorly understood, they risk costly failures and a loss of support for the research enterprise at large. Examples include Nixon’s 1971 War on Cancer, undertaken on the premise that a cure could be achieved in less than a decade, the drive to build an operational commercial fusion plant by the mid-1990s, and the National Plan to Address Alzheimer’s Disease, which failed to produce the effective treatments and prevention strategies promised by 2025. The contrasting laissez-faire approach is to hedge your bets. If the path to an advance is impossible to predict, then the wisest choice might be to distribute funding to as widely as possible. The main risk of this strategy is that spreading funding thinly may limit the resources available to the most promising research, resulting in the same negative outcomes as the interventionist approach: limited support for the most promising topics, slow progress, and delayed returns. In reality, at science agencies like the National Science Foundation and National Institutes of Health, program managers navigate between these two extremes, setting some funds aside to target high-priority areas and using the rest to cover the widest possible range of meritorious proposals. This middle path seems like the most rational way to proceed, but it still requires making choices. How much should be set aside for high priority topics? What should those topics be? How should we define merit? Expert opinion can provide a helpful guide, but leading experts can have remarkably different opinions about what matters and what should be prioritized. Moreover, experts and administrators alike can be risk averse, giving an edge to high-profile, well-established concepts. What’s really needed is a data-driven framework to help guide decision-making, one that doesn’t simply repackage prestige or incumbency. Recognizing breakthroughs years in advance Many breakthroughs fail to attract funding or recognition at the earliest stages of development. Katalin Karikó, for example, spent years struggling to win grants for work on mRNA that would eventually win her and Drew Weissman a Nobel Prize. Similar stories can be told about Jim Allison’s groundbreaking studies leading to the development of cancer immunotherapy, Stan Pruisner’s demonstration that prions can self-replicate without DNA, or Robin Warren and Barry Marshall’s proof that Helicobacter pylori, not stress, causes ulcers. Yet at some point, the scientific community recognizes and responds to transformative breakthroughs like these. How does that change happen? And what if science funders could identify the areas that are on the cusp of a breakthrough? Those questions led my collaborators and me to study how scientists responded to past breakthroughs. Based on patterns in that data, we developed a means of predicting future breakthroughs, using biomedicine as a proof of concept. It’s worth taking a moment to describe how our approach works. Briefly, our prediction process begins by grouping the 18 million or so peer-reviewed papers in PubMed, the authoritative database of biomedical research, into roughly 50,000 unique topics. A small subset of these topics are so widely acclaimed as breakthroughs that they have been recognized with a major prize like a Nobel or a Lasker Award. We theorized that studying the development of these outliers over time, especially before they gained acclaim, was the key to identifying future instances of them. After defining topics, we chose 21 representative breakthroughs and asked what they looked like before they won prestigious prizes. To answer that question, we re-ran our topic-mapping algorithm repeatedly, winding back the clock one year each time, stringing together the years to follow the progress of each field as it grew and advanced. We found that in each case, the years leading up to a discovery followed a pattern: a burst of papers on a new, rapidly evolving topic, many of which quickly became influential. These characteristics—the percent of papers that are new, the percentage of papers that are brought in from other topics, and the influence of each individual paper—can all be measured separately for any given topic. Together, they act as a predictive signal that is detectable an average of five years before a transformative discovery is made, and up to thirty years before the discovery receives a major prize. Scanning the current research landscape for topics that display this signal allows us to predict what work will likely produce a future breakthrough. Each year we analyzed includes four or five signals, a number that appears to have remained constant across a twenty year time frame. In their classic work on the sociology of science, Bruno Latour and Steve Woolgar established that the desire to participate in a major discovery is an important motivator for scientists as they consider whether they should take up (or abandon) a research problem. Although further work is needed, the simplest explanation for our results is that this behavior is widespread enough to detect at scale. A foundational advance, or something like it, draws the attention of scientists and causes them to change the direction of their research. They vote with their feet, staking their own reputation and careers by publishing on and citing the new idea. That upswell of interest is the foundation of our breakthrough signal. What kind of research does our model identify as a breakthrough? After building a model based on the patterns in our 21 preselected breakthroughs, we tested it by identifying all early signals of discovery from 1994 through 1997. Of the 18 signals we found in that time period, 17 can be traced forward in time to a breakthrough. Examples include super-resolution fluorescence microscopy (see the image above), the directed evolution of proteins and enzymes (Chemistry Nobel, 2018), and sequencing the human genome (National Medal of Science, 2008). The discovery of the role of leptin signaling in obesity is a particularly interesting case study. Around 1950, scientists noticed the existence of a type of lab mouse that suffered from a unique inherited form of obesity. When given the freedom to choose their own diet, these mice ate more than normal and preferred food that was high in fat. Researchers had few clues as to why the animals overate; early experiments pointed to the existence of a soluble ob factor found circulating in the bloodstream that regulated appetite, but its identity was unknown. In 1994, Jeffrey Friedman and colleagues identified and sequenced the ob gene, noting that the protein it encoded appeared to fit the profile of a circulating factor. A year later, a trio of high-profile publications demonstrated that ob was a hormone that regulated body weight and fat deposition by regulating appetite. One of these was co-authored by Friedman, who christened it leptin from the ancient Greek word for thin. Using our model, the data from 1996 make it clear this advance would become a breakthrough. Scientists had flocked to study the biology of the new hormone, generating the flurry of new papers and citations required to produce a signal. One of these demonstrated that serum leptin concentrations reflected the amount of adipose tissue in the human body, providing clinical validation of the earlier mouse studies. Before the identification of leptin, scientists were unable to point to a specific molecule that controlled appetite and adiposity, so that it was impossible to rule out non-physiological causes of obesity; its characterization fundamentally changed our concept of weight gain. In 2010, Friedman and fellow pioneer Douglas Coleman were awarded a Lasker for the discovery. Our work also identifies breakthroughs in clinical practice and behavioral and social sciences, even though these areas are less likely to draw the attention of major prize committees. One example that falls into this category is the introduction of endovascular aneurysm repair, a minimally invasive surgical procedure for the treatment of abdominal aortic aneurysm, a leading cause of death among Americans over the age of 65. Relative to the previous standard of care, it reduces in-hospital mortality by almost four-fold. In 2017, Timothy Chuter received the American College of Surgeons’ prestigious Jacobsen Innovation award for his multiple refinements to the technique. Another under-recognized breakthrough identified by our model is the development of standardized survey instruments to assess the quality of life for HIV+ patients. The antiretroviral cocktails introduced in the mid-1990s reduced AIDS mortality, but treatment came with serious side effects. The new evaluations showed that patients whose disease progressed had worse physical functioning than Americans with other chronic diseases, while those who were asymptomatic maintained a health-related quality of life on par with the overall US population. This evidence made it possible for patients and activists to argue that even in the absence of a total cure, and in spite of the side effects, alleviation of symptoms was a worthwhile priority for clinicians. My colleagues and I have failed to identify any significant recognition for the physicians and health policy experts who pioneered this advance, although in 2016, researchers called for the World Health Organization to set targets for good health-related quality of life as part of its framework to end the AIDS pandemic. From forecasting to funding How should science funders use our predictions? Any serious discussion of what we should do with this new capability needs to begin with an understanding of its limitations. We can’t (and shouldn’t) invest all of our resources in the small number of topics predicted to produce breakthroughs. Innovative new fields are born from existing ones; they rarely arise de novo. If funders don’t maintain a diverse portfolio, the breakthroughs of tomorrow will have no antecedents. Think of this as eating the seed corn, or killing the goose that lays the golden egg. There are also multiple goals of funding beyond basic scientific discovery, including translating discoveries into clinical practice, developing new technologies, supporting economic development, and training new scientists. The investments needed to accomplish these goals are likely different from those required to support emerging breakthroughs. Finally, we must be aware that we may not capture every instance of a breakthrough. The concept is fuzzy, and not every significant discovery is recognized with a major award. Further, breakthroughs are rare, meaning that our dataset is, by necessity, small. This makes formal estimates of accuracy challenging. Although our overall success rate appears to be high, any one signal may turn out to be a false positive. We found one apparent example: the development of the third generation COX-2 inhibitors, Vioxx and Celebrex, which were much celebrated in the early 2000s as effective but non-addictive pain relievers, meets all the algorithmic criteria of a breakthrough. Five years after it received FDA approval, researchers demonstrated that Vioxx was associated with serious cardiovascular complications, and the manufacturer voluntarily pulled the drug from the market. Celebrex remains available, although like other NSAIDs, it carries an FDA warning for increased cardiovascular risk. Decision makers who were overly focused on the breakthrough potential of this research might have wasted substantial resources nurturing an area that ultimately proved to be a failure—but so would those who relied on expert opinion at the time. That said, the potential benefits of funding the next mRNA vaccine or cancer immunotherapy years earlier than we might have are large. When we can’t assume the outcome of an action, it’s worth conducting an experiment. Can targeted support for areas that are poised to produce a breakthrough increase the return on scientific investment without cannibalizing future advances? With the necessary administrative infrastructure in place, conducting this experiment would be straightforward. First, identify all the breakthrough signals between 2018 and 2023, select half at random, and commit to a decade of investment. For biomedicine, a six year window should yield about 30 topics with the potential to produce a breakthrough. Providing strong support to half of these might be accomplished for $300 million a year. That’s roughly half of the recent annual budget of the NIH Common Fund or around 20% of the fiscal year 2025 budget for ARPA-H. After five years, then again at ten, compare to see which group — the one that was actively managed, or the control — produced more breakthroughs, and on what timescale. Although we used biomedicine as an example, the same experiment could just as well be run for physics, materials science, or any other discipline. Any attempt to undertake such an experiment should keep three points top of mind. First, we can predict the topic of future breakthroughs, but the people and vision for how to move the work forward are still important. In practice, this means success requires active program managers with the expertise to develop the science and the authority to do so, including by recruiting investigators. Second, we would be wise to learn from the failures of past attempts to fund transformative research. High among these are funding modestly repackaged work, confusing the genuinely novel with the merely unfamiliar, and relying too much on incumbent investigators. All of these risks can be mitigated by thoroughly and intelligently integrating high quality data into portfolio management. Finally, we need to have patience. Even with strong funding support, producing a breakthrough takes time. If supporting breakthroughs is the best way to nurture the birth of new fields, we also need to accurately describe and properly manage the other two stages, so that we invest wisely throughout the productive lifetime of ideas and divest once they reach the point of diminishing returns. We would benefit from more study of all of these phases, especially the transition from one to another. More research could answer questions like: When does a breakthrough become an established field? How do the availability of funding, the size and characteristics of the available workforce, and the accumulation of evidence that disagrees with prevailing models affect a field’s decline? Exactly how do old ideas give birth to new ones, and can we speed up the process? The more we understand about the dynamics of scientific progress, the better we can maximize the odds that our curiosity leads to results. I’d call that finding a way to make our own luck.
Takeaways: Supreme Court hands Trump massive wins on immigration agenda
The Supreme Court’s conservative majority delivered President Donald Trump a pair of significant affirmations of his immigration policy Thursday, paving the way for the administration to effectively remove more than 1 million people from the US and keep many others from entering in the first place.
Romeo Doubs' Exit Could Raise the Stakes for Jordan Love in Green Bay
Jordan Love and the Green Bay Packers are eyeing a bounce-back campaign in 2026. The Packers opened the 2025 season with a strong start, posting a 9-3-1 record through their first 13 games, before a flurry of injuries derailed Green Bay's Super Bowl hopes. Since taking over as Green Bay's starter under center, the Utah State product has shown flashes of a top-five signal-caller, though the team hasn't yet made it past the divisional round under his leadership.
UT Health San Antonio identifies the first potential probiotic treatment for lupus
Contact: Steven Lee, (210) 450-3823, lees22@uthscsa.edu Content provided by Claire Kowalick SAN ANTONIO, June 25, 2026 – Scientists at UT Health San Antonio, the academic health center of The University of Texas at San Antonio, found a link between a bacterium in the gut microbiome, or ecosystem, and lupus, which could lead to more effective […]
Misericordia University Students Earn Top Honors at Pennsylvania Academy of Science's 101st Annual Meeting
Misericordia University students earned multiple prestigious awards while showcasing undergraduate research at the 101st Annual Meeting of the Pennsylvania Academy of Science (PAS), held this year on the Misericordia University campus—the first time the statewide scientific organization has hosted its annual conference at the university.
Samsung Reportedly Starts OLED Panel Production for Apple’s First Foldable iPhone
Apple reportedly cleared Samsung Display to make OLED panels for its first foldable iPhone, with hinge issues still shaping launch timing.
Merck KGaA bolsters life sciences business with $11.3B Bio-Techne buy
The deal comes a matter of weeks after Kai Beckmann was promoted to CEO at Merck and signalled his intent to broaden the company's scope for M&A.
Databricks’ former AI chief thinks he can cut AI’s power bill by 1,000x
Un0 is an image-generation system tool that shows for the first time how the company's technology can replicate conventional AI systems.
Gillings-supported center helps public health teams prioritize infectious disease risks, from measles to the World Cup - UNC Gillings School of Global Public Health
June 25, 2026 When public health workers prepare for infectious disease threats, the question is rarely whether risk exists. It is where to focus first.
First-of-its-kind discovery earns UT Health San Antonio Mays Cancer Center fellow prestigious Helio NextGen Disruptor Award
Colton Frisco Jones, MD, a 2nd-year fellow at the Mays Cancer Center at UT Health San Antonio, the academic health center of The University of Texas at San Antonio (UT San Antonio), recently earned the prestigious Healio NextGen Disruptor Award at the American Society of Clinical Oncology (ASCO) 2026 annual meeting in Chicago.
'This is the next jump in technology': World's first sub-1nm chip keeps Moore's Law alive a little longer
IBM's NanoStack architecture has helped scientists cram 100 billion transistors onto a computer chip, delivering 50% better performance and consuming 70% less energy than the current generation.
US economy grew at 2.1% in first quarter
First-quarter GDP grew at 2.1%, above the expected 1.6%, as equipment investment in AI and computers along with consumer spending led growth.
Gallery | Jets First Round Rookies Visit Atlantic Health System's Goryeb Children's Hospital
Jets first round picks David Bailey, Omar Cooper Jr. and Kenyon Sadiq visited children at the Atlantic Health System's Goryeb Children's Hospital.
How should European scientists respond to the US AI kill switch?
Earlier in June, Europe’s worst fears of technological dependence were confirmed when the White House ordered the AI firm Anthropic to stop non-US citizens using its leading models. This kill-switch moment crystalised anxieties in Brussels that the continent, lagging the US on the creation of leading-edge AI models, is now a technological of vassal of Washington. The shock has specific implications for European scientists and universities. Some governments are now worried that with AI being integrated into labs, Donald Trump now has his finger hovering over an off switch for European science. “Having restrictions on this tool, it can have an impact on our own research,” said France’s research minister, Philippe Baptiste, at the VivaTech conference in Paris on June 18.Baptiste, himself a former academic, said that colleagues in mathematics had recently warned him they were now cut off from leading-edge US models, risking their work. “This model is not available anymore now because of the US restriction, and for the first time this had an impact on mathematics,” a field where large language models (LLMs) are making a significant contribution, said Baptiste. So, should European scientists avoid relying on US models in the future? Or would this be a self-harming overreaction? And how is AI being used in science, anyway? What happened?On June 12, it emerged that Washington, citing cybersecurity concerns, had ordered Anthropic to stop non-US citizens using two models: Claude Mythos 5, and Claude Fable 5, a version of Mythos but with guardrails to prevent abuse. Anthropic said Washington’s concerns were overblown. But forced to follow the order, yet with no way to check who was using the models, the company suddenly shut down access for everyone, US citizens included. There’s still no agreement on how to restore broad access. But last week, Bloomberg reported that select US companies, and the US government, still had access to Mythos despite the ban, but the EU’s cybersecurity agency Enisa had been shut out. Class division of researchersIn the longer term, access outside the US should be restored, said Marcel Salathé, co-director of the AI centre at the Federal Polytechnic School of Lausanne (EPFL), because a permanent restriction would be financially ruinous to US AI firms. “Even Trump will eventually budge to economic pressure,” he said.However, US AI firms might end up operating rather like banks, doing due diligence on users of their leading-edge AI models, he went on.European scientists are unlikely to fall foul of such checks, he said. But having a Chinese postgraduate in their lab, or doing a type of research the US disapproved of, could potentially result in access being denied. “It will create a sort of class division of researchers,” he said. More than frontier modelsHowever, successfully deploying AI in science is about far more than just having access to leading LLMs such as Mythos.Instead, many science-specific tools, most famously Alphafold, which predicts protein folding structures, require “far less” computing power to train than frontier models, well within the capabilities of European supercomputers, according to a recent analysis by the Arq Foundation, a Brussel-based AI think tank. Instead, tools such as Alphafold are possible because certain fields, like protein folding, weather prediction or astronomy, have large, clean, standardised datasets that can be used to train predictive models. Rather than compute, “data is the central constraint for AI for science,” the report says. For example, a less powerful physics model trained on CERN’s data “will be more valuable than the best model without certain data,” said Bengüsu Özcan, author of the report. European advantage?Europe could therefore steal a march by using its scientific data and infrastructure to create models US digital giants cannot. “They might actually match or go even beyond what these big [US] companies are doing,” said Özcan.Indeed, some European start-ups hope to create automated testing labs to create the kind of standardised data that could speed up the discovery of new materials. Materials scientists say there’s currently too little data to train models. AI scientistsHowever, even if the bottleneck for AI in science is often data, rather than compute, being at the mercy of the US for LLM access could still become a problem for European scientists. A new class of “AI scientists” based on leading LLMs is also emerging, Özcan’s report says.Unlike domain-specific tools like Alphafold, these try to automate day-to-day scientific work, by providing an overarching tool that coordinates specific models to synthesise existing literature, generate hypotheses or run analysis of data. The problem for Europe, however, is that these tools are sometimes based on US leading models. Google Deepmind’s AI Co-Scientist, for example, is built on Google’s Gemini LLM. Systematic failureThese scientific automation tools are still in their early stages, and still exhibit “systematic failures on scientific tasks,” Özcan’s report says. One of the problems is that the messy, day-to-day process of scientific discovery is largely not documented, meaning LLMs don’t have a good source of data to learn how scientists actually work. Meanwhile, some tasks, such as literature synthesis, don’t typically require access to leading edge models.However, the performance of AI scientific assistants could improve as companies such as Google pour resources into developing them. Rely on US“Unfortunately, for scientific assistants, there is not much we can do right now except rely on US frontier AI,” said Antoine Bosselut, a natural language processing expert based at EPFL. Chinese-built open models, which can run on local computers, lessening the risk of a shutdown, are touted as one alternative to US dependence. There’s also Mistral, once seen as Europe’s main AI hope, but the Paris-based company has seen its recent models fall behind in performance. But the Chinese alternatives are generally not as capable as US frontier AI models, said Bosselut, unless paired with fiddly, custom tools that allows them to act as independent agents. “Most scientists do not have the time,” he said. Don’t jump ship yetAlthough the kill switch moment is seen a warning shot for European scientists, it doesn’t mean labs should abandon US AI tools immediately. “I do not think the right response is simply to abandon US-based models and systems under the banner of sovereignty or independence,” said Mattias Björnmalm, secretary general of the Cesaer university association. “That would be an overreaction.”Related articlesEuropean sovereignty in AI requires ‘ugly trade-offs,’ say experts Robotic lab start-up makes case for €500M EU-funded materials testing facilityAI in science: is it useful? Instead, European researchers need to ask themselves whether they’re becoming dependent on technology that could be turned off in Washington, said Özcan. “They might not see this today, but they should really start asking this question,” she said. European researchers need a plan B, said Salathé. “I would recommend to every researcher, very proactively explore alternatives.”Own toolsIn addition, Björnmalm and others want European research institutions to develop their own scientific AI tools.Instead of signing AI deals with US digital giants, European universities should be using this money to create their own models, which may end up being superior for research, said Sabine Leonelli, an expert on the use of AI in science at the Technical University of Munich. “Universities in Europe seem to be happy to sign commercial contracts with US companies on the assumption [their AI tools] are better,” she said. But US frontier LLMs are typically opaque, and have been developed without independent scientific input, she said. “This is not good enough for science.”Last year, Swiss researchers released Apertus, an LLM designed to be completely transparent, from its development methods to its training data. The idea is that this makes scientific tools built on top of the model far more reproducible than with closed, commercial alternatives.“Europe needs more of this: serious capacity-building that gives researchers, universities and companies credible options,” said Björnmalm.
Inside Notre Dame MBA Global Business Immersion in Santiago, Chile - Notre Dame Business Mendoza College of Business
Global MBA students gain firsthand exposure to global capital markets and international business strategy in Santiago, Chile.
BlackBerry Sees New AI Opportunities as Embedded-Software Business Accelerates
BlackBerry lifted its fiscal 2027 outlook on higher first-quarter results, driven by embedded-software growth and expanding opportunities with artificial intelligence.
First NYC. Now DC. Can Mamdani’s win keep powering progressives?
Candidates on the left are on a roll in the biggest, bluest cities. But doubts remain about whether they can win a national race.
Esquire First Look: Robert Eggers Reveals Aaron Taylor-Johnson in Werwulf
The filmmaker behind ‘Nosferatu’ and ‘The VVitch ‘explores the historical inspiration behind his tale of a man struggling with his inner beast.
iPhone Ultra 2 Gets Green Light for Development, Says Leaker
Apple's second-generation foldable iPhone has officially been given the go-ahead for development, a prominent Chinese leaker claimed today. In a post on Weibo, the account known as Digital Chat Station said that the "iPhone Ultra 2 project" has been formally approved, and that the second book-style device will likely use the same display as the first-generation model expected later this year.
How a New York race became the first front in the AI industry’s midterm war
Competing AI interests poured millions into the Democratic primary, a taste of more spending to come this fall and elections beyond.
How is Derry City's new pitch 'World Cup standard'?
Ahead of Friday's first game back at the Brandywell, BBC Sport learns how a giant sewing machine has helped put Derry City's new hybrid pitch together.
The Painting That Is Still on Trial in South Korea: How the unending Korean War became a permanent excuse to criminalise expression
By Boram Jang, East Asia Researcher at Amnesty International In a Seoul courtroom in March this year, a prosecutor read out charges against Jeon Seung-il, a former art student, from an indictment first written in 1989. The language had not changed, nor had the charges. Thirty-seven years later, only the young defendant had grown old. In 1989, he was 23 years old in a South Korea still shaped by decades […]
Lionel Richie takes ill, cuts his St. Paul concert short
Lionel Richie announced the unexpected intermission at his concert on the first night of his tour with Earth, Wind & Fire.
Trump describes Burnham as 'the mayor of a town' and 'extremely liberal'
Donald Trump gives his first public reaction to the prospect of Andy Burnham becoming prime minister.
The Business of Beauty Global Forum: Our Place in Culture
Paloma Elsesser, Byunghoon Kim and Emma Dabiri discussed the global cultural shifts transforming today’s beauty standards on the first day of The Business of Beauty Global Forum 2026.
Mets trading David Peterson signals major deadline reset
David Peterson was the first domino for Mets.
Ohio State star Jeremiah Smith gets first ever notoriety by EA Sports
Ohio State superstar wide receiver Jeremiah Smith has received a first-ever ranking at launch for 'College Football 27' and the folks at EA Sports.
Travis Kelce's Journey: From Rookie to NFL Superstar and His Life with Taylor Swift
Travis Kelce is entering his 14th season in the NFL, all of which have been with the Kansas City Chiefs. After being selected No. 63 overall in the third round of the 2013 NFL Draft by Kansas City, Kelce played only a single special teams snap as a rookie, in a Week 2 game against the Dallas Cowboys. The seven-time All-Pro has set all-time marks for the Chiefs, such as surpassing Hall of Fame tight end Tony Gonzalez's 10,940 career receiving yards (13,002) and passing three-time first-team All-Pro Priest Holmes' 83 total career touchdowns (85).
'Need each other': Macron hosts Meloni after Trump rift
One of Europe's most prominent right-wing leaders will arrive on the French Riviera for her first bilateral summit with Macron, fresh from her fallout with Donald Trump
NBA Draft: Knicks continue spate of trades, deal No. 31 and 55 picks to Rockets after moving out of first round
Porsche unveils the new 911 GT4 R for global customer motorsport
For the first time, a car designed for global GT4 racing is based on the 911 platform.
Sister’s Gift Represents Transplant First at Sutter Health
Photo caption: Dr. Eric Miller adjusts the image focus on the da Vinci 5 robot as he performs Sutter’s first fully robotic living-donor kidney transplant. | June 2, 2026 Sutter’s California Pacific Medical Center (Sutter’s CPMC) in San Francisco has performed its first fully robotic living-donor kidney transplant, marking a significant milestone for the system’s […]
Buc-ee’s is finally open in Goodyear. A nearby small business prepares for its impact
As Buc-ee’s opens its first Arizona location in Goodyear, a nearby hot sauce manufacturer and gift shop prepares for an influx of tourists and road-trippers while weighing the impact on local business.
Space Shuttle Endeavour: California Science Center unveils vertical shuttle display
The California Science Center Wednesday provided the first public view of space shuttle Endeavour inside its permanent home -- in upright launch position with two rocket boosters and an external fuel tank.
After Jordan Kyrou trade, Blues are open for business — and positioned for a franchise-changing run
With four firsts after move, GM Doug Armstrong is preparing for a transaction marathon — "a 6-mile jog tomorrow and an 8-mile run Friday."
Diamondbacks Make a Decision on Carlos Santana
Carlos Santana’s brief stint in Arizona appears to be over after the Diamondbacks designated the veteran first baseman for assignment Wednesday.
Reese Witherspoon makes first public appearance with boyfriend Oliver Haarmann
Reese Witherspoon made her first public appearance with financier boyfriend Oliver Haarmann at the 'Elle' premiere in New York City.
Highlights of Aspen Ideas: Health, day two
On June 23, Aspen Ideas: Health ushered in the actual first full day — and evening — of programming. Here are some highlights from different tracks, or themes. NextGen Health Track: On the Frontiers of Brain Health “As belly size gets larger, the memory center in the brain gets smaller,” said Richard Isaacson, director...
Pints & Politics with WUNC's Colin Campbell in Pittsboro
To celebrate WUNC's 50th anniversary this year, we're hosting 50 events across North Carolina! Please join us on August 19 at BMC Brewing at The Plant in Pittsboro for Pints & Politics with WUNC Capitol Bureau Chief Colin Campbell! The event kicks off at 6 p.m.We'll chat about all things North Carolina politics, and your first pint will be on BMC Brewing in a special WUNC 50th anniversary pint glass! This event is free and open to the public, but an RSVP is encouraged as space is limited. Please RSVP at the link below to let us know if you are planning to join us. You can also submit a question for Colin in advance when you sign up to attend. We hope to see you soon!> RSVP Here
Jeremiah Smith earns first 99 launch rating in EA Sports College Football
Ohio State wide receiver Jeremiah Smith makes history as the first player to earn a 99 rating at launch in EA Sports College Football.
Jeremiah Smith earns first 99 launch rating in EA Sports College Football
Ohio State wide receiver Jeremiah Smith makes history as the first player to earn a 99 rating at launch in EA Sports College Football.
Dunnellon to mark America 250 with fireworks, entertainment
This year’s Fourth of July carries extra meaning for many citizens, as it represents the 250th anniversary of the signing of the Declaration of Independence. For the first time in
The 17 best popular science books of 2026 so far
The first six months of the year have brought us popular science reads on everything from consciousness to cosmology. Liz Else rounds up her favourites
Noah Hiles: These Pirates don’t deserve to be buyers at the MLB trade deadline
I’ve long believed the MLB standings aren’t worth viewing until Memorial Day. With the regular season being such an extended grind, the first...
NBA rumors: The latest on Jaylen Brown's Celtics future, the Knicks' offseason plans and Anthony Edwards
The first night of the draft came and went without any big moves but there's plenty to be done
Scientists May Have Detected The First Signature of a Black Hole's Event Horizon
We're getting closer to the brink.
GTA 6 Ultimate Edition Pre-Order Details Confirm Major New Gameplay Features, Giving Players A First Look At Safehouses And Custom Vehicles
The latest GTA 6 Ultimate Edition news reveals plenty of fresh gameplay details, including fishing, fencing, fixing up classic cars and much more.
Why healthcare CIOs must fix their foundations before scaling AI
Healthcare leaders are focused on generative AI innovation, but the organizations most likely to succeed may be those investing first in architecture, governance and interoperability.
From The Sports Desk: Cristiano Ronaldo makes history and joins in World Cup scoring barrage
Ronaldo scored twice yesterday against Uzbekistan, which made him the first player to score in six World Cups, from 2006 through this tournament.
From The Sports Desk: Cristiano Ronaldo makes history and joins in World Cup scoring barrage
Ronaldo scored twice yesterday against Uzbekistan, which made him the first player to ever score in six different World Cups, from 2006 through this current tournament.
'Fingerprints' of black hole's event horizon detected for first time
Scientists have detected the "fingerprints" of a black hole's event horizon -- the boundary from which nothing can escape -- for the first time, according to research published on Wednesday. The scien...
Pat Kelsey & The Snub
Sunrise/ Sunset/ Since the beginning it hasn’t changed yet/ People fly high begin to lose sight/ You can’t see very clearly when you’re in flight — “On Your Way Down” Allen Toussaint To be honest I didn’t pay much attention initially when Pat Kelsey was first asked Monday morning about not being invited to attend […]
First look at the Endeavor Space Shuttle at the California Science Center
Science fans will soon get the chance to see the Space Shuttle Endeavor in its ready-to-launch position at the California Science Center in Exposition Park this November.
Hollister’s First-Ever Target Collection Reveals a 3-Step Growth Strategy Any Business Can Copy
Hollister's first home collection is a move from closet share to lifestyle share, and a growth playbook any founder can borrow.
Latest injury has 4-time Cy Young winner thinking retirement
Tigers starting pitcher Justin Verlander was expected to come off the injured list and start the June 21 game against the White Sox. It would have been his first game since March. But after working his way through a hip injury that landed him on the IL, the 43-year-old Verlander suffered a ...
This is the real reason your cat purrs—and it’s not what you think - Futura-Sciences
The Genetic Mystery Behind the Purr If you thought your cat’s purr was just an automatic sound of happiness—like you sighing with satisfaction after a good meal—science begs to differ. Researchers from Kyoto University’s Wildlife Research Center in Japan have identified, for the first time, genetic underpinnings to this ancient...
Google’s New $100 Speaker Makes a Weak Case for Gemini in the Home
The Google Home Speaker is the first new device of its kind to come from Alphabet Inc. in six years. In that time, Google has reshaped itself as an industry leader in artificial intelligence, with its Gemini platform now ubiquitous across consumer hardware like smartphones and web services like Search, Workspace and YouTube.
NFL offseason power rankings: No. 31 New York Jets try to put Aaron Glenn's horrific first season behind them
Daily Bean: Trades! Trades! Trades! More Rumors, Bruins Draft Board
Where do we begin? The Boston Bruins did not grab any headlines yesterday. They signed P-Bruins goaltender Simon Zajicek to […] The post Daily Bean: Trades! Trades! Trades! More Rumors, Bruins Draft Board appeared first on Boston Hockey Now.
The hidden stakes of the birthright citizenship case: healthcare for babies
The birthright citizenship case in front of the US Supreme Court is about much more than just citizenship. It’s also about an issue that was little discussed in court arguments: babies’ immediate access to safety net programs and medical tests that need to be done within the first couple days of life.
A NASA satellite caught a giant tsunami doing something no one expected
A Pacific-wide tsunami triggered by a magnitude 8.8 Kamchatka earthquake gave scientists their first detailed satellite view of a major tsunami in motion. The observations revealed unexpected wave behavior and helped uncover a larger earthquake rupture than earlier models predicted.
Service meets science: Meet the first graduate of UAB’s Master of Science in AI in Medicine
UAB’s first graduate of the M.S. in AI in Medicine program blends clinical training with artificial intelligence, highlighting how physicians can use AI to reduce burnout, improve patient care and shape the future of healthcare.
France Identifies First Case of Ebola
The patient is a doctor who had traveled to the Democratic Republic of Congo, the health ministry said. Workers are racing to trace those who may have had contact.
How a $0 co-pay saves billions
Bringing down drug costs is the first step to improve health care affordability.
France confirms first Ebola case in doctor returning from DR Congo
The patient is in isolation, following strict biosafety protocols to prevent risk of spread in France.
Entertainment calendar
Please email entertainment listings to entertainment518@digitalfirstmedia.com. Wednesday, June 24, 2026 PROCTORS: 432 State Street, Schenectady. Chicago, 7:30 pm. www.atproctors.org. SARATOGA PERFORMING ARTS CENTER: 108 Avenue of The Pines,…
Da’Realyst Clark Named Athlon Sports Preseason All-American
KENT, Ohio – Kent State University return specialist Da'Realyst Clark has been named to the Athlon Sports 2026 Preseason All-America First Team as a kick ret...
Here are Hogsett’s top campaign donors. Many do business with the city
A first-time analysis of Hogsett’s campaign fundraising shows it's largely driven by law firms, engineering companies and other powerbrokers.
CEO of FNB Honored for Business Excellence, Leadership
Vincent Delie, chairman, president and CEO of F.N.B. Corp. and its largest subsidiary, First National Bank, received two national awards.
Democratic socialists just dominated New York — and are coming for 2028
The group is asking members across all 250 chapters to weigh who they want to back in the next presidential election and why, according to a plan first shared with POLITICO.
It's not too late to order USA TODAY's 3 Knicks championship page prints
USA TODAY Sports has crafted three championship page prints to commemorative the New York Knicks' first NBA championship in 53 years.
NBA Draft first round reaction: Winners! Losers! Surprises! Steals!
Lakers Draft Pick Has Surprising Kobe Bryant Connection
The Los Angeles Lakers took wing, Cameron Carr, with the No. 24 overall selection, a player with a ton of upside and a strong reputation. The post Lakers Draft Pick Has Surprising Kobe Bryant Connection appeared first on LA Sports Report.
Aces fall to Liberty in first matchup of the year
LAS VEGAS – The Aces certainly know what to expect now.
2026 NBA Draft Grades: Analysis for AJ Dybantsa, Darryn Peterson, Cameron Boozer, rest of first-round picks
Adam Finkelstein has the breakdown of each pick in one of the best drafts in recent memory
Friday’s World Cup match in Seattle draws conversations about politics and Pride
For the first time in World Cup history, Friday’s Game has been designated “Welcome to Seattle: This is How we Pride,” a kickoff to Pride weekend in Seattle.
Chinese scientists love Blackpink’s Jennie so much they named a fish after her
At less than 9mm, Jennie’s bumblebee goby is the smallest of its genus and the first to be found in China.
NBA Draft 2026: Champion Knicks trade out of first round via swaps with Lakers, Mavericks and Suns
First Look: The new 37mm Grand Seiko Spring Drive UFA Lake Suwa SLGB015
The new Grand Seiko Evolution 9 collection SLGB015 is a 37mm interpretation of the blue Lake Suwa dial, with the UFA movement.
2026 NBA Draft grades, first-round pick-by-pick analysis: Wizards get A+ for selecting AJ Dybantsa No. 1
A review argues the family dog may become science’s unlikely ally against autism
This peer-reviewed Perspective synthesizes a decade of research on a surprising candidate for autism science: the laboratory Beagle. Drawing together scattered studies, the review authors argue that dogs carrying engineered changes in the Shank3 gene reproduce core human features of autism spectrum disorder, including social withdrawal, altered sensory responses, and reduced attention to the eyes of a face. The synthesis assembles, for the first time in one place, the parallels between mutant dogs and autistic people, alongside early signals that oxytocin, a psychedelic, and a third compound may soften these traits. The authors frame the dog as a complementary, ethically governed model, not a replacement for existing ones.
Dusty May pens goodbye letter to University of Michigan
JUST IN: Dusty May has released his first statement since leaving the Michigan men’s basketball team and becoming the head coach of the Dallas Mavericks:
First patient receives neural stem cell therapy in groundbreaking UCI Health Huntington's disease clinical trial
World’s first neural stem cell phase 1b/2a clinical trial for condition leverages innovative technology
Angels Haunted by Trades in Loss to Orioles
Two past trade deals came back to haunt the Los Angeles Angels during the series opener against the Baltimore Orioles on Monday. The Angels lost 6-1 to the Orioles, with two of the Halos’ former players shining during the game. In the first inning, former Angels outfielder Taylor Ward hit a leadoff home run to […] The post Angels Haunted by Trades in Loss to Orioles appeared first on LA Sports Report.
Don Toliver expands world tour with first stop at Sacramento’s Golden 1 Center
The ‘Octane’ World Tour’s ‘Nitrous’ expansion will kick off at Sacramento’s Golden 1 Center.
NBA Draft 2026 Day 1 discussion
Okay ladies and gentlemen. Today is the BIG DAY! The first round of the 2026 NBA Draft is tonight at 8 p.m. ET. Watch it on ABC (WJLA-TV) or ESPN. The Washington Wizards have the first pick of this thing barring a trade. And besides some initial reports in May about the Utah Jazz wanting […]
Apple releases new AirPods beta firmware, including first build for AirPods Max 2
Following the release of iOS 27 beta 2, Apple is rolling out the first firmware beta for AirPods Max 2, alongside second beta builds for other supported AirPods models.
Marathon's First PVE Mode Launches Next Month And Sounds Great
I want to play Vault Breaker right now, but have to wait until July 21
Senate votes to block Trump from resuming Iran war
The Senate passed the first war powers resolution since the start of the Iran conflict, but Republicans argue it does not have the force of law.
Vanderbilt Health is first US site for advanced clinical testing platform
Part of the cobas pro integrated solutions produced by Roche, the platform will speed up laboratory testing and improve patient care.